Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation

European Journal of Biochemistry

Volumn 265, Issue 1, 1999, Pages 449-456

  Juarranz, Maria G ^b   Van Rampelbergh, Jean ^b   Gourlet, Philippe ^b   De Neef, Phillippe ^b   Cnudde, Johnny ^b   Robberecht, Patrick ^b   Waelbroeck, Magali ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NONE

Author keywords

Agonist; Antagonist; Receptor domains; VIP receptors

Indexed keywords

CHIMERIC PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE;

ADENYLATE CYCLASE; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; LIGANDS; PEPTIDE FRAGMENTS; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RECOMBINANT FUSION PROTEINS; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA;

EID: 0001124990     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00769.x     Document Type: Article

References (34)

1. 1. Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K. & Nagata, S. (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8, 811-819.
2. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for the vasoactive intestinal peptide. FEBS Lett. 334, 3-8.
3. 3. Couvineau, A., Rouyer-Fessard, C., Darmoul, D., Maoret, J.J., Carrero, I., Ogier-Denis, E. & Laburthe, M. (1994) Human intestinal VIP receptor: cloning and functional expression of two cDNA enconding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200, 769-776.
4. 4. Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J.F., De Neef, P., Waelbroeck, M. & Robberecht, P. (1994) Molecular cloning and functional characterization of a VIP receptor from SUP-TI lymphoblasts. Biochem. Biophys. Res. Commun. 205, 1617-1627.
5. 5. Harmar, A.J., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J.R., Rawlings, S.R., Robberecht, P., Said, S.I., Sreedharan, S.P., Wank, S.A. & Waschek, J.A. (1998) International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50, 265-270.
6. 1) receptors stimulate inositol phosphate synthesis in transfected CHO through interaction with different G proteins. Biochim. Biophys. Acta 1357, 249-255.
7. 7. Usdin, T.B., Bonner, T.I. & Mezey, E. (1994) Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135, 2662-2680.
8. 8. Vertongen, P., Schiffmann, S.N., Gourlet, P. & Robberecht, P. (1997) Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides 18, 1547-1554.
9. 1 receptor agonist. Peptides 18, 1539-1545.
10. 1 receptor. Peptides 18, 1555-1560.
11. 11. Gourlet, P., Vandermeers-Piret, M.C., Rathé, J., De Neef, P., Cnudde, J., Robberecht, P. & Waelbroeck, M. (1998) Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes. Eur. J. Pharmacol. 348, 95-99.
12. 12. Ciccarelli, E., Vilardaga, J.P., De Neef, P., Di Paolo, E., Waelbroeck, M., Bollen, A. & Robberecht, P. (1994) Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regulat. Pept. 54, 397-407.
13. 2 receptor subclass. Peptides 18, 403-408.
14. 14. Salomon, Y., Londos, C. & Rodbell, M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
15. 15. O'Donnell, M., Garippa, R.J., Rinaldi, N., Selig, W.M., Simko, B., Renzetti, L., Tannu, S.A., Wasserman, M.A., Welton, A. & Bolin, D.R. (1994) Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist: Part I - in vitro and in vivo bronchodilator studies. J. Pharmacol Exp. Ther. 270, 1282-1288.
16. 16. Holtmann, M.H., Hadac, E.M. & Miller, L.J. (1995) Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. J. Biol. Chem. 270, 14394-14398.
17. 17. Du. K., Nicole, P., Couvineau, A. & Laburthe, M. (1998) Construction of chimeras between human VIP1 and secretin receptors: identification of receptor domains involved in selectivity towards VIP, secretin and PACAP. Ann. N.Y. Acad. Sci. 865, 386-389.
18. 18. Vilardaga, J.P., De Neef, P., Di Paolo, E., Bollen, A., Waelbroeck, M. & Robberecht, P. (1995) Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem. Biophys. Res. Commun. 211, 885-891.
19. 19. Holtmann, M.H., Hadac, E.M., Ulrich, C.D. & Miller, L.J. (1996) Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor. J. Pharmacol. Exp. Ther. 279, 555-560.
20. 20. Gaudin, P., Couvineau, A., Maoret, J.J., Rouyer-Fessard, C. & Laburthe, M. (1995) Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding. Biochem. Biophys. Res. Commun. 211, 901-908.
21. 21. Vilardaga, J.P., Di Paolo, E., Bialek, C., De Neef, P., Waelbroeck, M., Bollen, A. & Robberecht, P. (1997) Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulphide bridges are essential for receptor function. Eur. J. Biochem. 246, 173-180.
22. 22. Laburthe, M., Couvineau, A., Gaudin, P., Maoret, J.J., Rouyer-Fessard, C. & Nicole, P. (1996) Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1 and other members of their new family of G-protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Ann. N.Y. Acad. Sci. 805, 94-111.
23. 23. Nicole, P., Du, K., Couvineau, A. & Laburthe, M. (1998) Site-directed mutagenesis of human VIP1 versus VIP2 receptors. Ann. N.Y. Acad. Sci. 865, 378-381.
24. 24. Couvineau, A., Rouyer-Fessard, C., Maoret, J.J., Gaudin, P., Nicole, P. & Laburthe, M. (1996) Vasoactive intestinal peptide VIP1 receptor. Three non adjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide. J. Biol. Chem. 271, 12795-12800.
25. 25. Hashimoto, H., Ogawa, N., Hagihara, N., Yamamoto, K., Imanishi, K., Nogi, H., Nishino, A., Fujita, T., Matsuda, T., Nagata, S. & Baba, A. (1997) Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation. Mol. Pharmacol. 52, 128-135.
26. 26. Couvineau, A., Rouyer-Fessard, C., Fournier, A., St Pierre, S., Pipkorn, R. & Laburthe, M. (1984) Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. Biochem. Biophys. Res. Commun. 121, 493-498.
27. 27. Turner, J.T., Jones, S.B. & Bylund, D.B. (1986) A fragment of vasoactive intestinal peptide, VIP (10-28), is an antagonist of VIP in the colon carcinoma cell line, HT-29. Peptides 7, 849-854.
28. 28. Gozes, I., McCune, S.K., Jacobson, L., Warren, D., Moody, T.W., Fridkin, M. & Brenneman, D.E. (1991) An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257, 959-966.
29. 29. Gourlet, P., Vilardaga, J.P., De Neef, P., Waelbroeck, M., Vandermeers, A. & Robberecht, P. (1996) The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides 17, 825-829.
30. 30. Dong, M., Wang, Y., Pinon, D.I., Hadac, E.M. & Miller, L.J. (1999) Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffmity labelling. J. Biol. Chem. 274, 903-909.
31. 31. Gourlet, P., Vilardaga, J.P., De Neef, P., Vandermeers, A., Waelbroeck, M., Bollen, A. & Robberecht, P. (1996) Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. Eur. J. Biochem. 239, 349-355.
32. 32. Di Paolo, E., De Neef, P., Moguilevsky, N., Petry, H., Bollen, A., Waelbroeck, M. & Robberecht, P. (1998). Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Let. 424, 207-210.
33. 33. Vilardaga, J.P., Di Paolo, E., De Neef, P., Waelbroeck, M., Bollen, A. & Robberecht, P. (1996) Lysine 173 residues within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin. Biochem. Biophys. Res. Commun. 218, 842-846.
34. 34. Donnelly, D. (1997) The arragement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett. 409, 431-436.